Valuation: Boule Diagnostics AB

Market Cap 134M 13.9M 12.15M 11.21M 10.33M 19.47M 1.34B 19.91M 52.7M 656M 52.2M 51.05M 2.26B P/E 2026 *
-13.7x
P/E 2027 * 15.6x
Enterprise Value 331M 34.29M 29.97M 27.65M 25.49M 48.04M 3.3B 49.11M 130M 1.62B 129M 126M 5.57B EV / Sales 2026 *
0.73x
EV / Sales 2027 * 0.66x
Free-Float
53.64%
Yield 2026 *
-
Yield 2027 * -
1 day-8.00%
1 week-9.45%
Current month-7.01%
1 month+4.55%
3 months-9.45%
6 months-36.58%
Current year-29.74%
1 week 2.75
Extreme 2.75
3.84
1 month 2.75
Extreme 2.75
3.99
Current year 2.75
Extreme 2.75
5.68
1 year 2.75
Extreme 2.75
6.78
3 years 2.75
Extreme 2.75
12.62
5 years 2.75
Extreme 2.75
61.9
10 years 2.75
Extreme 2.75
108.88
Manager TitleAgeSince
Chief Executive Officer - 22/06/2026
Director of Finance/CFO 54 11/02/2026
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Chairman 73 01/01/2021
Chairman 74 01/01/2023
Director/Board Member 59 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
27/02/23 Buy

Chief Financial Officer

8,000 0.0206%
06/02/23 Buy

Director

7,083 0.0182%
17/02/22 Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-8.00%-9.45%-66.50%-71.72% 15.11M
-1.97%+1.03%+25.30%+1.37% 202B
-0.58%+2.40%+4.64%-14.27% 145B
-14.15%-15.08%-33.08%-2.38% 142B
-1.32%-1.65%-57.93%-16.31% 66.32B
-2.40%-7.03%+12.54%-7.47% 50.58B
-0.11%+1.53%-24.62%-31.81% 44.81B
-3.41%-2.11%+12.98%+11.17% 38.44B
-2.44%-1.98%+24.27%+36.75% 37.13B
-4.00%-2.52%-17.27%-22.32% 29.89B
Average -2.36%-2.38%-11.97%-11.70% 75.66B
Weighted average by Cap. -1.31%-2.16%-3.12%-5.14%

Financials

2026 *2027 *
Net sales 453M 47.01M 41.08M 37.91M 34.94M 65.86M 4.53B 67.32M 178M 2.22B 177M 173M 7.63B 483M 50.14M 43.82M 40.44M 37.27M 70.25M 4.83B 71.81M 190M 2.37B 188M 184M 8.14B
Net income -9.77M -1.01M -886K -818K -754K -1.42M -97.65M -1.45M -3.84M -47.82M -3.81M -3.72M -165M 8.6M 892K 779K 719K 663K 1.25M 85.89M 1.28M 3.38M 42.06M 3.35M 3.28M 145M
Net Debt 197M 20.39M 17.82M 16.44M 15.16M 28.57M 1.96B 29.2M 77.31M 962M 76.58M 74.9M 3.31B 185M 19.14M 16.73M 15.44M 14.23M 26.82M 1.84B 27.42M 72.57M 903M 71.89M 70.32M 3.11B
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
17/07/26 SEK 3.450 -8.00% 254,379
16/07/26 SEK 3.750 -0.27% 6,231
15/07/26 SEK 3.760 -2.08% 23,537
14/07/26 SEK 3.840 +1.05% 1,634
13/07/26 SEK 3.800 -0.26% 4,349
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.450SEK
Average target price
3.800SEK
Spread / Average Target
+10.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BOUL Stock